The present invention is to provide a light emitting material, for an organic EL device, exhibiting higher light emitting efficiency, and particularly, to provide a blue light emitting material, wherein the light emitting material comprises a compound of the following General Formula (1):

##STR00001## X is an aryl group including a tertiary amine structure, and Y is a phenyl group having an alkyl or aryl substituent at one ortho position.

The present invention is to provide a light emitting material, for an organic EL device, exhibiting higher light emitting efficiency, and particularly, to provide a blue light emitting material, wherein the light emitting material comprises a compound of the following General Formula (1):

##STR00001## X is an aryl group including a tertiary amine structure, and Y is a phenyl group having an alkyl or aryl substituent at one ortho position.

A condensed cyclic compound and an organic light-emitting device, the compound being represented by Formula 1:
(A.sub.1).sub.a1-(L.sub.1).sub.b1-(A.sub.2).sub.a2  <Formula 1> wherein, in Formula 1, A.sub.1 is a group represented by Formula 2-1, below, a1 is 1, 2, or 3, and, when a1 is 2 or greater, two or more A.sub.1s are identical to or different from each other, A.sub.2 is a group represented by Formula 2-2, below, a2 is 1, 2, or 3, and, when a2 is 2 or greater, two or more A.sub.2s are identical to or different from each other, ##STR00001##

A condensed cyclic compound and an organic light-emitting device, the compound being represented by Formula 1:
(A.sub.1).sub.a1-(L.sub.1).sub.b1-(A.sub.2).sub.a2  <Formula 1> wherein, in Formula 1, A.sub.1 is a group represented by Formula 2-1, below, a1 is 1, 2, or 3, and, when a1 is 2 or greater, two or more A.sub.1s are identical to or different from each other, A.sub.2 is a group represented by Formula 2-2, below, a2 is 1, 2, or 3, and, when a2 is 2 or greater, two or more A.sub.2s are identical to or different from each other, ##STR00001##

The present disclosure may disclose a new crystal form D of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one ((1S,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl) methanesulfonic acid salt, preparation method therefor and a medicinal use. Compared to the existing crystalline forms, this new crystalline form has clear advantages with respect to solubility, stability, and the preparation process.

Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, and methods for their use and production.

Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, and methods for their use and production.

Provided herein are compounds, compositions, and methods for rapid isolation of nucleic acids from a sample.

Provided herein are compounds, compositions, and methods for rapid isolation of nucleic acids from a sample.

The present invention relates to compounds of Formula (I), (I) wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as defined herein. The invention further relates to herbicidal compositions which comprise a compound of Formula (I), to their use for controlling weeds, in particular in crops of useful plants.

##STR00001##